why choose us

Clinical Trials Search

Showing 18,010 of 132,963 result(s)
Testing the Safety of the Anti-cancer Drugs Tazemetostat and Belinostat in Patients With Lymphomas That Have Resisted Treatment

Status: Completed

Condition: Recurrent B-Cell Non-Hodgkin Lymphoma

Interventions: Given IV

Date: 2022-11-23

Investigation of Medical Management to Prevent Episodes of Diverticulitis Trial

Status: Completed

Condition: Diverticulitis

Interventions: Please see description of Medi for All arm

Date: 2022-11-23

Study to Evaluate of the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa

Status: COMPLETED

Condition: Hidradenitis Suppurativa

Interventions: Ruxolitinib cream is a topical formulation applied as a thin film to affected areas.

Date: 2022-11-23

Comparison of Endotracheal Tube Fixation Methods in Prone Position

Status: COMPLETED

Condition: Fixation Device; Complications

Interventions: Use of the thomas tube holder for endotracheal tube fixation in patients operated in the prone position

Date: 2022-11-23

Evuzamitide in PET;CT to Measure Potential Therapeutic Response in ATTR

Status: COMPLETED

Condition: Transthyretin Amyloidosis

Interventions: Amyloid reactive protein used as imaging agent in whole body SPECT-CT imaging

Date: 2022-11-23

Study of INV-102 Ophthalmic Solution in Adults With Acute Infectious Keratoconjunctivitis

Status: COMPLETED

Condition: Acute Infectious Keratoconjunctivitis

Interventions: INV-102 Ophthalmic Solution

Date: 2022-11-23

A Noninterventional, Single-Center Feasibility Study to Evaluate Measures of Heart Failure Risk

Status: COMPLETED

Condition: Heart Failure

Interventions: Observation only

Date: 2022-11-23

Brivaracetam to Reduce Neuropathic Pain in Chronic SCI: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Status: Completed

Condition: Spinal Cord Injuries

Interventions: Drug dosage will be individually titrated for each participant with a goal of 100mg BID according to the following dose escalation protocol that we us

Date: 2022-11-23

Phase 1b of Lurbinectedin in Combination With Weekly Paclitaxel and Bevacizumab in Platinum-resistant Ovarian Cancer

Status: Completed

Condition: Ovarian Cancer

Interventions: Given by (IV) vein

Date: 2022-11-23

Study to Assess the Safety and Pharmacokinetics of ATL-001 (Ciclopirox Olamine) in Healthy Volunteers

Status: Completed

Condition: Adverse Effect of Drugs and Medicaments in Therapeutic Use

Interventions: On the morning of Day 1 to Day 5, each participant will receive a single oral dose of ATL-001 or placebo

Date: 2022-11-22